Indeed, we observed an increased CD54 expression, a greater IFN-γ production by CTL and the presence of a NK receptor repertoire with preferential expression of activating molecules in our cohort of CLL patients. Here, ICAM1 is linked to B-cell chronic lymphocytic leukemia.